Recent treatments of aplastic anemia. The International Group on SAA.

Authors
Category Primary study
JournalNouvelle revue francaise d'hematologie
Year 1991
The treatment of severe aplastic anemia has been modified recently by the demonstration that Cyclosporine A is active alone or in combination leading to more than 50% response rate. Combination or sequential treatments with ATG seem to be better than such drug separately but this must be studied in randomized studies. Long term follow-up is necessary to assess the rate of malignant transformation. Growth factors have been recently introduced. G or GM-CSF seem to be active. IL-3 has not been proven to be effective in very small non randomized study. Allogeneic bone marrow transplantation is the best treatment with a matched related donor, progress must be achieved in methods of conditioning and GVH prophylaxis when a matched unrelated donor is used.
Epistemonikos ID: a5814e0e905a9cad4896dd4f4e69468fc5a4397a
First added on: Aug 29, 2023